Variant report
Variant | nsv978481 |
---|---|
Chromosome Location | chr17:20252145-20261474 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CCDC144C-1 | chr17:20254251-20254284 | NR_023380 |
2 | lnc-CCDC144C-1 | chr17:20254570-20254711 | NR_023380 |
3 | lnc-CCDC144C-1 | chr17:20261192-20261409 | NR_023380 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368024222 | chr17:20254259-20254260 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs149532100 | chr17:20254261-20254262 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs534376574 | chr17:20254267-20254268 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs201588554 | chr17:20254282-20254283 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs560337019 | chr17:20254477-20254478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527933094 | chr17:20254479-20254480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552462483 | chr17:20254480-20254481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564840565 | chr17:20254499-20254500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532008129 | chr17:20254533-20254534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371324523 | chr17:20254578-20254579 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs143042302 | chr17:20254598-20254599 | Weak transcription | lncRNA | n/a | Overlapped CNVs | mRNA abundance |
12 | rs200813224 | chr17:20254601-20254602 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs201988690 | chr17:20254627-20254628 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs548374815 | chr17:20254630-20254631 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs566672524 | chr17:20254631-20254632 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs200084662 | chr17:20254748-20254749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78019973 | chr17:20254786-20254787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570753866 | chr17:20254787-20254788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537836905 | chr17:20254867-20254868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556539643 | chr17:20254995-20254996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2909506 | chr17:20255066-20255067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541922841 | chr17:20255200-20255201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553908274 | chr17:20255246-20255247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146200087 | chr17:20255255-20255256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546033243 | chr17:20255293-20255294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564600440 | chr17:20255323-20255324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532065741 | chr17:20255460-20255461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543827533 | chr17:20255555-20255556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562523037 | chr17:20255564-20255565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529764598 | chr17:20255566-20255567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548314096 | chr17:20255675-20255676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566609229 | chr17:20255701-20255702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2261906 | chr17:20255772-20255773 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
34 | rs552385240 | chr17:20255829-20255830 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs371378983 | chr17:20255850-20255851 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2261905 | chr17:20255855-20255856 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570623088 | chr17:20256003-20256004 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538166099 | chr17:20256010-20256011 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142924533 | chr17:20256029-20256030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189619558 | chr17:20256042-20256043 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535498403 | chr17:20256048-20256049 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182321766 | chr17:20256071-20256072 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540381299 | chr17:20256126-20256127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2694322 | chr17:20256174-20256175 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs75599080 | chr17:20256200-20256201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200684793 | chr17:20256201-20256202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs62066885 | chr17:20256203-20256204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572234609 | chr17:20256219-20256220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186872055 | chr17:20256261-20256262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190313122 | chr17:20256281-20256282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 17440070 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:20254400-20268200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr17:20255800-20256200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |